Intra-articular injection of hydrocortisone acetate is commonly used in the treatment of arthritic conditions.According to Hollander et al.(1951) , Thorn was the first to inject hydrocortisone into an inflamed knee joint of a patient with rheumatoid arthritis; he observed a prompt relief of symptoms with a dose of 10mg. A generalized remission of the rheumatoid arthritis coincided and was ascribed to an unusual sensitivity of the patient to hydrocortisone. Hollander et extensively, giving more than 17,000 injections in doses of 25 to 50mg for each joint, but systemic effects were not noted.These workers and otheres emphasized that intra-articular treatment could be used in patients with contraindications to systemic hydrocortisone therapy. Reports on systemic effects were summarized in Table I .
Although systemic effects had been anticipated or actually experienced when larger doses were used, the response to larger doses of hydrocortisone acetate intra-articularly has not been studied systematically.
In an attempt to overcome resistance to intra-articular injection of hydrocortisone acetate in a patient, in whom the usual dose of less than 50mg did not give satisfactory results, the dose of hydrocortisone acetate was increased to 250 mg and eventually to 600mg. Excellent clinical results were obtained. The effect was more intense locally and had a longer duration.
While 50 mg produced a local effect for seven days in average, 250mg produced an effect which persisted for about three weeks.
In the subjects receiving these larger doses of hydrocortisone acetate definite systemic effects were observed. It was then decided to seek objective evidence of the systemic effects by means of eosinophil counts and corticosteroid excretion studies.
The route of injection is obviously important because when the same dose of hydrocortisone acetate was administered intramuscularly practically no systemic effect was observed. In its free form hydrocortisone has similar effects whether it is taken orally or intramuscularly. Hydrocortisone acetate, however, was reported by Conn(1951) to be less effective intramuscularly than orally. This was confirmed by Perera et al.(1951) and Thorn et al.(1953 hydrocortisone acetate. Both caused increased nitrogen excretion but the increase after hydrocortisone acetate was slower and less distinct. The increase in corticosteroid excretion followed the same pattern. The increase in 17-ketosteroids excretion was present after cortisone acetate but very slight or absent after hydrocortisone acetate. Dixon(1953) compared the systemic effects of intra-articular and intramuscular injection of cortisone acetate in patients with rheumatoid arthritis by means of clinical observation and by changes in the volume and viscosity of the fluid in the contralateral knee. The effects were of the similar magnitude. The complete absence of clinical effect by intramuscular injection of hydrocortisone acetate in our experience stimulated us to compare the systemic effect of intramuscular injection with intra-articular injection. (1)(Intra-articular), III(1)(Intramuscular) and IV(1)(Intra-articular). 
Reliability of the methods
The Porter-Silber reaction is considered to be specific for 17-21-dihydroxy-20-ketosteroids: hydrocortisone, cortisone, their tetrahydro derivatives and 11-desoxy-17-hydroxycorticosterone. Although some 17-ketosteroids are formed from hydrocortisone,most of the metabolites of hydrocortisone are found among PorterSilbr reacting steroids. A greater portion of these steroids are known to be conjugated with glucuronic acid. Any remarkable increase of Porter-Silber reacting steroids after the injection of hydrocortisone is probably due to the excretion of its metabolites. The Gornal and McDonald reaction is positive for all PorterSilber reacting steroids as well as desoxycoticosterone, progesterone, testosterone, etc. This method always gives higher values then Porter-Silber's method.
The total eosinophil count is influenced by adrenal cortical hormones. Eosinopenia is seen in patients with Cusing's syndrome and in patients treated with ACTH or adrenal steroids.Eosinophilia is seen in patients with Addison's disease or adrenalectomized subjects.On the other hand, the response of eosinophils to ACTH is not always a satisfactiory test for adrenal function since other factors also 2.
Intramuscular hydrocortisone acetate
The minimal clinical effects produced by intramuscular injection of hydrocortisone acetate were in agreement with the poor increase in steroid excretion and minimal drop in eosinophil counts, except in one instance in which 600mg was administered. Salassa et al.(1952) ascribed the poor effect to a slow rate of absorption.
3.
Intra-articular hydreortisone acetate
Intra-articular injection of hydrocortisone acetate produced local effect lasting from a few days to a few weeks. Some joints were refractory to a dose of 50mg or less. By increasing the dose to 250mg,excellent local antirheumatic effect was produced in every instance and the duration of the local effect was at least three times as long as with the 50mg dose. The larger doses usually produced systemic effects.
The large dose may be used in two ways. First, in monoarticular involvement without contraindications to systemic hydrocortisone therapy, the large dose not only overcome hydrocortisone-resistant joints but also decrease the required number of injections thereby diminishing the risk of infection. Second, in some cases in which sustained hypercortical state is required or long term replacement therapy is indicated intra-articular hydrocortisone acetate may be used at intervals of 4 to 6 days in doses of more than 250mg aiming at the systemic effects. This is particularly useful in psychiatric abnormalities or unconscious subjects.
The mechanism of the sustained systemic effects are not clear. Zacco et al. (1954) showed that most of the hydrocortisone acetate injected into a joint was attached to the cells of synovial membrane, while the free hydrocortisone is mainly found in the synovial fluid.
Somehow, the joint cavity as a whole appeares to act as a depot. De-esterification of hydrocortisone acetate probably takes place slowly by the enzyme system of the joint tissues.
SUMMARY
Five patients with chronic active rheumatoid arthritis received intramuscular or intra-articular injection of hydrocortisone acetate. The dose was more than 250mg.
Clinical systemic effects,eosinopenia, and increased steroids excretion were observed following intra-articular injections. These effects were less pronounced or absent following intramuscular injections.
